Abbott Laboratories/ US0028241000 /
08/11/2024 22:10:00 | Chg. +1.29 | Volume | Bid02:00:00 | Ask02:00:00 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
116.59USD | +1.12% | 5.69 mill. Turnover: 468.66 mill. |
115.21Bid Size: 100 | 116.50Ask Size: 300 | 202.22 bill.USD | 1.78% | 35.55 |
Assets
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 8,063 | 5,905 | 5,935 | 5,730 | 5,705 | ||||||
Intangible Assets | 8,588.3000 | 5,735 | 6,198 | 5,562 | 4,539 | ||||||
Long-Term Investments | 273.6000 | 119 | 229 | 4,041 | 2,947 | ||||||
Fixed Assets | - | - | 26,014 | 27,092 | 25,890 | ||||||
Inventories | 3,792.3000 | 2,693 | 2,643 | 2,599 | 2,434 | ||||||
Accounts Receivable | 7,612.9000 | 3,986 | 3,586 | 3,418 | 3,248 | ||||||
Cash and Cash Equivalents | 10,802.2000 | 3,475 | 4,063 | 5,001 | 18,620 | ||||||
Current Assets | 31,322.6000 | 19,247 | 15,261 | 14,155 | 26,776 | ||||||
Total Assets | 67,234.9000 | 42,953 | 41,275 | 41,247 | 52,666 |
Liabilities
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 1,797 | 1,026 | 1,064 | 1,081 | 1,178 | ||||||
Long-term debt | - | - | 3,408 | 5,871 | 20,681 | ||||||
Liabilities to Banks | 2,081.8000 | 3,164 | 4,382 | 3,127 | 1,322 | ||||||
Provisions | 655.4000 | 175 | 270 | 430 | 188 | ||||||
Liabilities | 40,421.7000 | 17,686 | 19,636 | 19,921 | 31,949 | ||||||
Share Capital | - | - | 12,383 | 12,734 | 13,027 | ||||||
Total Equity | 26,813.2000 | 25,267 | 21,639 | 21,326 | 20,717 | ||||||
Minority Interests | 92.3000 | 96 | 113 | 115 | 179 | ||||||
Total liabilities equity | 67,234.9000 | 42,953 | 41,275 | 41,247 | 52,666 |
Income Statement
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 39,873.9000 | 21,848 | 20,247 | 20,405 | 20,853 | ||||||
Depreciation (total) | - | 791 | 1,548 | 1,472 | 1,353 | ||||||
Operating Result | 8,084.5000 | 2,629 | 2,599 | 2,867 | 3,185 | ||||||
Interest Income | -513.2000 | -90 | -73 | -58 | -332 | ||||||
Income Before Taxes | 6,262.6000 | 2,521 | 2,518 | 3,183 | 1,413 | ||||||
Income Taxes | 299.7000 | 138 | 797 | 577 | 350 | ||||||
Minority Interests Profit | - | - | - | - | - | ||||||
Net Income | 5,962.9000 | 2,576 | 2,284 | 4,423 | 1,400 |
Per Share
Cash Flow
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 9,314.4000 | 3,324 | 3,675 | 2,966 | 3,203 | ||||||
Cash Flow from Investing Activities | -6,081.3000 | -3,929 | -202 | 406 | -248 | ||||||
Cash Flow from Financing | 716.1000 | -6,696 | -2,742 | -2,236 | 11,147 | ||||||
Decrease / Increase in Cash | 3,989.3000 | -7,327 | 588 | 938 | 13,619 | ||||||
Employees | 91,000 | 69,000 | 77,000 | 74,000 | 75,000 |